Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AURA-BIOSCIENCES-INC-128747413/news/Aura-Biosciences-Announces-First-Patient-Dosed-in-Global-Phase-3-CoMpass-Trial-Evaluating-the-Safety-45532379/?utm_source=whatsapp&utm_medium=social&utm_campaign=share